| Literature DB >> 25155551 |
Mikhail Krasavin1, Andrey V Sosnov2, Ruben Karapetian3, Igor Konstantinov3, Olga Soldatkina3, Elena Godovykh3, Fedor Zubkov4, Ruoli Bai5, Ernest Hamel5, Andrei A Gakh6.
Abstract
We discovered a new chemical class of antiproliferative agents, 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides. SAR-guided optimization of the two distinct terminal fragments yielded a compound with 120 nM potency in an antiproliferative assay. Biological activity profile studies (COMPARE analysis) demonstrated that 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides act as tubulin inhibitors, and this conclusion was confirmed via biochemical assays with pure tubulin and demonstration of increased numbers of mitotic cells following treatment of a leukemia cell line.Entities:
Keywords: Chemotherapeutic agents; DU-145; Prostate cancer; Rational single-molecule polypharmacy; Screening; Tubulin inhibitor
Mesh:
Substances:
Year: 2014 PMID: 25155551 PMCID: PMC4191898 DOI: 10.1016/j.bmcl.2014.07.089
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823